A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach

Citations Over TimeTop 10% of 2005 papers

Abstract

Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small molecules that bind to tubulin and cause mitotic arrest are of immense interest. A large number of synthetic and natural compounds with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly. Using the recently determined X-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to determine the binding modes of a set of structurally diverse colchicine site inhibitors. These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with molecular dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.

Related Papers

• → Interactions of colchicine with tubulin(1991)283 cited
• → β-III Tubulin Levels Determine the Neurotoxicity Induced by Colchicine-Site Binding Agent Indibulin(2022)10 cited
• → Biochemical determination of tubulin-microtubule equilibrium in cultured cells(1979)40 cited
• → B‐ring of colchicine and its role in taxol‐induced tubulin polymerization(1986)4 cited
• → A modified colchicine-binding assay for the measurement of total and microtubule-derived tubulin in rat liver(1983)15 cited